1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kaufman DS, Shipley WU and Feldman AS:
Bladder cancer. Lancet. 374:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Botteman MF, Pashos CL, Redaelli A, Laskin
B and Hauser R: The health economics of bladder cancer: A
comprehensive review of the published literature.
Pharmacoeconomics. 21:1315–1330. 2003. View Article : Google Scholar
|
5
|
Malmström PU: Why has the survival of
patients with bladder cancer not improved? BJU Int. 101:267–269.
2008. View Article : Google Scholar
|
6
|
Falebita OA, Sweeney P and Lee G: Urine
cytology in the evaluation of urological malignancy revisited: is
it still necessary. Urol Int. 84:45–49. 2010. View Article : Google Scholar
|
7
|
Mengual L, Lozano JJ, Ingelmo-Torres M,
Gazquez C, Ribal MJ and Alcaraz A: Using microRNA profiling in
urine samples to develop a non-invasive test for bladder cancer.
Int J Cancer. 133:2631–2641. 2013.PubMed/NCBI
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Heneghan HM, Miller N and Kerin MJ: MiRNAs
as biomarkers and therapeutic targets in cancer. Curr Opin
Pharmacol. 10:543–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Hunter MP, Ismail N, Zhang X, et al:
Detection of microRNA expression in human peripheral blood
microvesicles. PLoS ONE. 3:e36942008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chim SS, Shing TK, Hung EC, Leung TY, Lau
TK, Chiu RW and Lo YM: Detection and characterization of placental
microRNAs in maternal plasma. Clin Chem. 54:482–490. 2008.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Genovesi LA, Anderson D, Carter KW, Giles
KM and Dallas PB: Identification of suitable endogenous control
genes for microRNA expression profiling of childhood
medulloblastoma and human neural stem cells. BMC Res Notes.
5:5072012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Chang KH, Mestdagh P, Vandesompele J,
Kerin MJ and Miller N: MicroRNA expression profiling to identify
and validate reference genes for relative quantification in
colorectal cancer. BMC Cancer. 10:1732010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zheng G, Wang H, Zhang X, et al:
Identification and validation of reference genes for qPCR detection
of serum microRNAs in colorectal adenocarcinoma patients. PLoS ONE.
8:e830252013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Cheng L, Montironi R, Davidson DD and
Lopez-Beltran A: Staging and reporting of urothelial carcinoma of
the urinary bladder. Mod Pathol. 22(Suppl 2): S70–S95. 2009.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Asaga S, Kuo C, Nguyen T, Terpenning M,
Giuliano AE and Hoon DS: Direct serum assay for microRNA-21
concentrations in early and advanced breast cancer. Clin Chem.
57:84–91. 2011. View Article : Google Scholar
|
20
|
Zheng G, Wang H, Zhang X, Yang Y, Wang L,
Du L, Li W, Li J, Qu A, Liu Y and Wang C: Identification and
validation of reference genes for qPCR detection of serum microRNAs
in colorectal adenocarcinoma patients. PLoS One. 8:e830252013.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Vandesompele J, De Preter K, Pattyn F,
Poppe B, Van Roy N, De Paepe A and Speleman F: Accurate
normalization of real-time quantitative RT-PCR data by geometric
averaging of multiple internal control genes. Genome Biol.
3:research0034. 2002, View Article : Google Scholar : PubMed/NCBI
|
22
|
Adam L, Wszolek MF, Liu CG, Jing W, Diao
L, Zien A, Zhang JD, Jackson D and Dinney CP: Plasma microRNA
profiles for bladder cancer detection. Urol Oncol. 31:1701–1708.
2013. View Article : Google Scholar
|
23
|
Selth LA, Townley SL, Bert AG, Stricker
PD, Sutherland PD, Horvath LG, Goodall GJ, Butler LM and Tilley WD:
Circulating microRNAs predict biochemical recurrence in prostate
cancer patients. Br J Cancer. 109:641–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Köberle V, Kronenberger B, Pleli T, et al:
Serum microRNA-1 and microRNA-122 are prognostic markers in
patients with hepatocellular carcinoma. Eur J Cancer. 49:3442–3449.
2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Huang X, Liang M, Dittmar R and Wang L:
Extracellular microRNAs in urologic malignancies: Chances and
challenges. Int J Mol Sci. 14:14785–14799. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Liu R, Zhang C, Hu Z, et al: A
five-microRNA signature identified from genome-wide serum microRNA
expression profiling serves as a finger-print for gastric cancer
diagnosis. Eur J Cancer. 47:784–791. 2010. View Article : Google Scholar
|
27
|
Bediaga NG, Davies MP, Acha-Sagredo A, et
al: A microRNA-based prediction algorithm for diagnosis of
non-small lung cell carcinoma in minimal biopsy material. Br J
Cancer. 109:2404–2411. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Bargaje R, Hariharan M, Scaria V and
Pillai B: Consensus miRNA expression profiles derived from
interplatform normalization of microarray data. RNA. 16:16–25.
2010. View Article : Google Scholar :
|
29
|
Chen X, Ba Y, Ma L, et al:
Characterization of microRNAs in serum: A novel class of biomarkers
for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
30
|
Pritchard CC, Kroh E, Wood B, Arroyo JD,
Dougherty KJ, Miyaji MM, Tait JF and Tewari M: Blood cell origin of
circulating microRNAs: A cautionary note for cancer biomarker
studies. Cancer Prev Res (Phila). 5:492–497. 2012. View Article : Google Scholar
|
31
|
Scheffer AR, Holdenrieder S, Kristiansen
G, von Ruecker A, Müller SC and Ellinger J: Circulating microRNAs
in serum: novel biomarkers for patients with bladder cancer? World
J Urol. 32:353–358. 2014. View Article : Google Scholar
|
32
|
Zhu HT, Dong QZ, Wang G, Zhou HJ, Ren N,
Jia HL, Ye QH and Qin LX: Identification of suitable reference
genes for qRT-PCR analysis of circulating microRNAs in hepatitis B
virus-infected patients. Mol Biotechnol. 50:49–56. 2012. View Article : Google Scholar
|
33
|
Lardizábal MN, Nocito AL, Daniele SM,
Ornella LA, Palatnik JF and Veggi LM: Reference genes for real-time
PCR quantification of microRNAs and messenger RNAs in rat models of
hepatotoxicity. PLoS ONE. 7:e363232012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Song J, Bai Z, Han W, Zhang J, Meng H, Bi
J, Ma X, Han S and Zhang Z: Identification of suitable reference
genes for qPCR analysis of serum microRNA in gastric cancer
patients. Dig Dis Sci. 57:897–904. 2012. View Article : Google Scholar
|
35
|
Kreth S, Heyn J, Grau S, Kretzschmar HA,
Egensperger R and Kreth FW: Identification of valid endogenous
control genes for determining gene expression in human glioma.
Neurooncol. 12:570–579. 2010.
|
36
|
Hu Z, Dong J, Wang LE, et al: Serum
microRNA profiling and breast cancer risk: The use of miR-484/191
as endogenous controls. Carcinogenesis. 33:828–834. 2012.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
Identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
38
|
Wang Y, Tang N, Hui T, Wang S, Zeng X, Li
H and Ma J: Identification of endogenous reference genes for
RT-qPCR analysis of plasma microRNAs levels in rats with
acetaminophen-induced hepatotoxicity. J Appl Toxicol. 33:1330–1336.
2013.PubMed/NCBI
|
39
|
Andersen CL, Jensen JL and Ørntoft TF:
Normalization of real-time quantitative reverse transcription-PCR
data: A model-based variance estimation approach to identify genes
suited for normalization, applied to bladder and colon cancer data
sets. Cancer Res. 64:5245–5250. 2004. View Article : Google Scholar : PubMed/NCBI
|